Terms: = Lung cancer AND RBM10, GPATC9, 8241, ENSG00000182872, CTD-2522E6_5, GPATCH9, KIAA0122, P98175, MGC1132, DXS8237E, ZRANB5, MGC997 AND Clinical Outcome
803 results:
1. clinical and Imaging Characteristics of SARS-CoV-2 Breakthrough Infection in Hospitalized Immunocompromised Patients.
Lee JE; Kim J; Hwang M; Kim YH; Chung MJ; Jeong WG; Jeong YJ
Korean J Radiol; 2024 May; 25(5):481-492. PubMed ID: 38627873
[TBL] [Abstract] [Full Text] [Related]
2. Remote Monitoring and Data Collection for Decentralized clinical Trials.
Daly B; Brawley OW; Gospodarowicz MK; Olopade OI; Fashoyin-Aje L; Smart VW; Chang IF; Tendler CL; Kim G; Fuchs CS; Beg MS; Zhang L; Legos JJ; Duran CO; Kalidas C; Qian J; Finnegan J; Pilarski P; Keane H; Shen J; Silverstein A; Wu YL; Pazdur R; Li BT
JAMA Netw Open; 2024 Apr; 7(4):e246228. PubMed ID: 38607626
[TBL] [Abstract] [Full Text] [Related]
3. Spreading Through Air Spaces And Thinking About lung Metastases.
M Castro P; Rei J; Silva C; Miranda J; Guerra M
Port J Card Thorac Vasc Surg; 2023 Oct; 30(3):31-35. PubMed ID: 38499034
[TBL] [Abstract] [Full Text] [Related]
4. A novel investigation into the negative impact of opioid use on the efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients.
Guo H; Li Y; Lin J; Li D; Yang J; Wang J; Mao J; Wang Y; Yan X
Int Immunopharmacol; 2024 Mar; 129():111611. PubMed ID: 38325047
[TBL] [Abstract] [Full Text] [Related]
5. Sarcomas With RAD51B Fusions Are Associated With a Heterogeneous Phenotype.
Chang HY; Dermawan J; Sharma A; Dickson B; Turashvili G; Torrence D; Nucci M; Chiang S; Oliva E; Kirchner M; Stenzinger A; Mechtersheimer G; Antonescu C
Mod Pathol; 2024 Feb; 37(2):100402. PubMed ID: 38141829
[TBL] [Abstract] [Full Text] [Related]
6. Circulating Immune Proteins: Improving the Diagnosis and clinical outcome in Advanced Non-Small Cell lung cancer.
Torres-Martínez S; Calabuig-Fariñas S; Gallach S; Mosqueda M; Munera-Maravilla E; Sirera R; Navarro L; Blasco A; Camps C; Jantus-Lewintre E
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139416
[TBL] [Abstract] [Full Text] [Related]
7. Comprehensive molecular analysis of driver mutations in non-small cell lung carcinomas and its correlation with PD-L1 expression, An Indian perspective.
Aggarwal A; Sharma S; Brar Z; Kumar V; Kumar A; Katara R; Mohanty SK
Pathol Res Pract; 2024 Jan; 253():155013. PubMed ID: 38096714
[TBL] [Abstract] [Full Text] [Related]
8. [Comparison of Quality of Life of the Patients Three Months after Uniportal
and Multiportal Thoracoscopic Lobectomy].
Zhang Q; Dai W; Wei X; Xiang R; Gu H; Hu P; Liu M; Chen W; Gong H; Liang Y; Zhang S; Peng W; Shi Q; Li Q; Yu N
Zhongguo Fei Ai Za Zhi; 2023 Nov; 26(11):843-850. PubMed ID: 38061886
[TBL] [Abstract] [Full Text] [Related]
9. Poor Efficacy of Immune Checkpoint Inhibitors Plus Chemotherapy in lung cancer Patients with EGFR/ERBB2 Exon 20 Insertion.
Zheng Y; Fu Y; Chen Y; Li Q; Liu T; Ding Z
Curr Oncol; 2023 Nov; 30(11):9929-9939. PubMed ID: 37999141
[TBL] [Abstract] [Full Text] [Related]
10. Identification of dual STRN-NTRK2 rearrangements in a high grade sarcoma, with good clinical response to first-line larotrectinib therapy.
Lin R; Mallick AB; Wang ZX; Brown SA; Lu B; Jiang W
Diagn Pathol; 2023 Oct; 18(1):116. PubMed ID: 37865792
[TBL] [Abstract] [Full Text] [Related]
11. clinical outcomes of
Hansen KH; Johansen JS; Urbanska EM; Meldgaard P; Hjorth-Hansen P; Kristiansen C; Stelmach M; Santoni-Rugiu E; Ulhøi MP; Dydensborg AB; Dünweber C; Andersen JL
Acta Oncol; 2023 Dec; 62(12):1775-1783. PubMed ID: 37815923
[TBL] [Abstract] [Full Text] [Related]
12. Co-Occurring Alterations in Multiple Tumor Suppressor Genes Are Associated With Worse outcomes in Patients With EGFR-Mutant lung cancer.
Stockhammer P; Grant M; Wurtz A; Foggetti G; Expósito F; Gu J; Zhao H; Choi J; Chung S; Li F; Walther Z; Dietz J; Duffield E; Gettinger S; Politi K; Goldberg SB
J Thorac Oncol; 2024 Feb; 19(2):240-251. PubMed ID: 37806385
[TBL] [Abstract] [Full Text] [Related]
13. clinical and imaging features of interstitial lung disease in cancer patients treated with trastuzumab deruxtecan.
Baba T; Kusumoto M; Kato T; Kurihara Y; Sasaki S; Oikado K; Saito Y; Endo M; Fujiwara Y; Kenmotsu H; Sata M; Takano T; Kato K; Hirata K; Katagiri T; Saito H; Kuwano K
Int J Clin Oncol; 2023 Dec; 28(12):1585-1596. PubMed ID: 37787866
[TBL] [Abstract] [Full Text] [Related]
14. Thyroid transcription factor-1 expression in lung neuroendocrine tumours: a gender-related biomarker?
La Salvia A; Siciliani A; Rinzivillo M; Verrico M; Baldelli R; Puliani G; Modica R; Zanata I; Persano I; Fanciulli G; Bassi M; Mancini M; Bellino S; Giannetta E; Ibrahim M; Panzuto F; Brizzi MP; Faggiano A
Endocrine; 2024 Feb; 83(2):519-526. PubMed ID: 37775725
[TBL] [Abstract] [Full Text] [Related]
15. GK-1 effectively reduces angiogenesis and prevents T cell exhaustion in a breast cancer murine experimental model.
Hernández-Aceves JA; Cervantes-Torres J; Torres-García D; Zuñiga-Flores FJ; Patiño-Chávez OJ; Peña Agudelo JA; Aguayo-Flores JE; Garfias Y; Montero-León L; Romero-Romero L; Pérez-Torres A; Fragoso G; Sciutto E
Cancer Immunol Immunother; 2023 Nov; 72(11):3825-3838. PubMed ID: 37736849
[TBL] [Abstract] [Full Text] [Related]
16. De Novo Design and Development of a Nutrient-Rich Perfusate for Ex Vivo lung Perfusion with Cell Culture Models.
Huang L; Vellanki RN; Zhu Z; Wouters BG; Keshavjee S; Liu M
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685927
[TBL] [Abstract] [Full Text] [Related]
17. Efficacy of Tyrosine Kinase Inhibitors in Primary Driver-Gene-Positive Combined Small-Cell lung cancer: A Retrospective Study.
Shi Z; Wei J; Sun W; Zeng X; Zhou H; Song Z
Clin Lung Cancer; 2023 Dec; 24(8):717-725.e1. PubMed ID: 37482500
[TBL] [Abstract] [Full Text] [Related]
18. Identification of age- and immune-related gene signatures for clinical outcome prediction in lung adenocarcinoma.
Zhou A; Zhang D; Kang X; Brooks JD
Cancer Med; 2023 Aug; 12(16):17475-17490. PubMed ID: 37434467
[TBL] [Abstract] [Full Text] [Related]
19. Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study.
Nicholson BD; Oke J; Virdee PS; Harris DA; O'Doherty C; Park JE; Hamady Z; Sehgal V; Millar A; Medley L; Tonner S; Vargova M; Engonidou L; Riahi K; Luan Y; Hiom S; Kumar H; Nandani H; Kurtzman KN; Yu LM; Freestone C; Pearson S; Hobbs FR; Perera R; Middleton MR
Lancet Oncol; 2023 Jul; 24(7):733-743. PubMed ID: 37352875
[TBL] [Abstract] [Full Text] [Related]
20. Identification of a novel survival predictor, CSF2RB, for female lung cancer in never smokers (LCNS) by a bioinformatics analysis.
Zhou YY; Sun XJ; Liu JQ; Xiang LL
Medicine (Baltimore); 2023 Jun; 102(23):e34019. PubMed ID: 37335631
[TBL] [Abstract] [Full Text] [Related]
[Next]
